Arbor Biotechnologies

Arbor Biotechnologies is a gene editing company developing potentially curative genomic medicines and founded by Feng Zhang.

Ship sailing through stormy seas
Biotech

Arbor sails into rocky gene editing waters with $74M

The raise will support ABO-101, a CRISPR-based gene editing therapy for primary hyperoxaluria type 1 that is set to enter a phase 1 trial soon.
Darren Incorvaia Mar 18, 2025 6:30am
parasail Blue Lagoon parachute

Gilead's accounting chief hits the exit—Chutes & Ladders

Mar 14, 2025 8:30am
Fierce Biotech Fierce 15 logo

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am